Ongoing 23 May 2023

NEO-IMPACT

A feasibility study is to test the safety and effectiveness of immunotherapy in addition to standard of care chemotherapy, as part of preoperative therapy in patients with pancreatic cancer.

Enquire

Trial overview

Clinical Area

Medical Oncology

Disease / Condition

Pancreatic

Study Phase

Trial Identifiers

Registration number: ACTRN12622000378729

https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=383607&isReview=true

GenesisCare Location(s)

North Shore

Principal Investigator(s)

Dr Sarah Maloney

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.

First name *

Last name *

Email *

Phone *

State *

Postcode *

What is the reason for enquiry?

How would you prefer to be contacted? *

Phone

By submitting you acknowledge we will use the information you are providing to contact you about your enquiry. For more information about how we handle your personal information, please refer to the GenesisCare Privacy Policy.

NEO-IMPACT

Trial overview

Thank you for submitting.

An unexpected error has occurred.

How can we help?

GenesisCare

Website policies

Contact us

Media & Social